These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12123826)

  • 21. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation.
    Motta G; Rojkjaer R; Hasan AA; Cines DB; Schmaier AH
    Blood; 1998 Jan; 91(2):516-28. PubMed ID: 9427705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP; Gurewich V; Johnstone M; Pannell R
    Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):896-900. PubMed ID: 11792853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
    Hooley E; McEwan PA; Emsley J
    J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolylcarboxypeptidase: a cardioprotective enzyme.
    Mallela J; Yang J; Shariat-Madar Z
    Int J Biochem Cell Biol; 2009 Mar; 41(3):477-81. PubMed ID: 18396440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma contact activation: a revised hypothesis.
    Schmaier AH
    Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
    Kleniewski J; Donaldson VH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):198-202. PubMed ID: 8419923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.
    Rabey FM; Gadepalli RS; Diano S; Cheng Q; Tabrizian T; Gailani D; Rimoldi JM; Shariat-Madar Z
    Curr Med Chem; 2012; 19(24):4194-206. PubMed ID: 22664251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
    Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR
    J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
    Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade.
    Okada H; Watanabe Y; Kikuta T; Kobayashi T; Kanno Y; Sugaya T; Suzuki H
    J Am Soc Nephrol; 2004 Sep; 15(9):2404-13. PubMed ID: 15339989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis.
    Gurewich V; Johnstone M; Loza JP; Pannell R
    FEBS Lett; 1993 Mar; 318(3):317-21. PubMed ID: 8440390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.
    Wojta J; Holzer M; Hufnagl P; Christ G; Hoover RL; Binder BR
    Am J Pathol; 1991 Oct; 139(4):911-9. PubMed ID: 1928306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.